Cellectis Presents Preclinical Data from its First Allogeneic Dual CAR T-cell Product Candidate UCART20x22 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma at the American Association for Cancer Research (AACR) 2022 Annual Meeting
Preclinical data demonstrated POC with robust in vitro and in vivo anti-tumor activity UCART20x22 allogeneic…
Addressing Cross-Border Transit Demand at the New Huanggang Port: Weixin Pay, Wonder and Koon Wing Motors Join Forces to Introduce ‘Wonder Transit X’ Smart Mobility Platform, Driving Digital Transformation of Green Minibuses and Fostering Public Transit Integration Between HK and the Chinese Mainland
Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum
Onchain Foundation Becomes Strategic Shareholder of Trust Square Ecosystem AG to Accelerate Global Innovation Platform
Champion REIT Announces 2026 Interim Results
Guoquan (2517.HK) 2026 Interim Results: Dual Growth in Scale and Efficiency, Powered by the Dual Drivers of Membership Stickiness and Product Matrix